After-hours movers: Apple, Amazon, and Google all fall as results disappoint
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rises as oil slide offers respite after Fed rate hike
- Oil falls 2% to one-week low as Middle East supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Paradium AI (PAAI) Halted, News Pending
Google releases new AI 'Bard' to testers ahead of public release
February 6, 2023 2:49 PM ESTGoogles parent company, Alphabet Inc, (NASDAQ: GOOG) announced in a blog post on Monday that the company is planning to launch a chatbot service called Bard. Bard is powered by LaMDA, Google's AI that can generate human-like prose. The technology company opened the conversational AI service to test users for feedback, and will be followed by a public release in the coming... More
Evercore ISI Removes Apple (AAPL) From Tactical Outperform List
February 3, 2023 11:30 AM ESTEvercore ISI analyst Amit Daryanani reiterated an Outperform rating and $190.00 price target on Apple (NASDAQ: AAPL)
The analyst comments "We are removing AAPL from the Tactical Outperform list as the potential catalyst for our call took place yesterday during their earnings print. AAPL reported Dec-qtr results of $117B/1.88 vs. street at $124B/1.95 with sales declining 5% y/y due to headwinds from f/x (~800bps), production... More
Gilead Sciences shares gain after topping expectations despite lower remdesivir sales
February 3, 2023 9:46 AM ESTGilead Sciences (NASDAQ: GILD) shares rallied in early Friday trading in reaction to the company's latest earnings report, which saw it beat top and bottom-line consensus expectations.
The biopharmaceutical company posted fourth-quarter earnings of $1.67 per share, $0.17 above the analyst consensus estimate of $1.50, while revenue for the quarter came in at $7.4 billion, beating expectations of $6.66 billion.
The company's revenue increased year-over-year, primarily due to increased sales in Oncology, HIV, and hepatitis C virus. However, this was partially offset by... More
Deutsche Bank Downgrades Ford (F) to Sell 'on operational shortfalls and earnings risk'
February 3, 2023 6:08 AM ESTDeutsche Bank analyst Emmanuel Rosner downgraded Ford (NYSE: F) from Hold to Sell with a price target of $11.00 (from $13.00).
The analyst comments "We are downgrading our Ford rating to Sell, following its large 4Q22 miss and new aggressive 2023 guidance, which in our view showcase considerable... More
